Amphion Innovations PLC Order Dismissing DataTern Case (3333V)
November 02 2017 - 3:00AM
UK Regulatory
TIDMAMP
RNS Number : 3333V
Amphion Innovations PLC
02 November 2017
Amphion Innovations plc
("Amphion" or "the Company")
Order Dismissing DataTern Case
London and New York, 2 November 2017 - Amphion Innovations plc
(AIM: AMP), the developer of medical, life science, and technology
businesses, announces that on 20 October 2017 the case brought by
DataTern Inc. ("DataTern"), a wholly-owned subsidiary of Amphion,
against MicroStrategy Inc. and certain of its customers was
dismissed.
The reason for the case dismissal was the withdrawal of
DataTern's legal counsel and the inability of DataTern to identify
and appoint a successor counsel in the short time frame set by the
Court.
It remains DataTern's considered opinion that the 502 and 402
patents are both valid and being infringed by a wide range of
companies that are practicing this critical art. In order to pursue
these claims though, DataTern needs to be able to fund the expenses
in the programme and efforts to find a suitable funding source and
successor legal counsel are continuing.
For further information please contact:
Amphion Innovations Tel: +1 (212) 210
6224
Charlie Morgan
Panmure Gordon Limited (Nominated Adviser Tel: +44 (0)20 7886
and Corporate Broker) 2500
Freddy Crossley / Duncan Monteith (Corporate
Finance)
Charlie Leigh-Pemberton (Corporate Broking)
Northland Capital Partners Limited (Joint Tel: +44 (0)20 3861
Corporate Broker) 6625
Patrick Claridge / David Hignell (Corporate
Finance)
John Howes (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933
8780 or
Mike Wort/ Paul McManus amphion@walbrookpr.com
About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and
technology businesses. We use our extensive experience in company
building to invest and build shareholder value in high growth
companies in the US and UK. Amphion has significant shareholding in
a small number of Partner Companies developing proven technologies
targeting substantial commercial marketplaces. The Amphion model
has been refined to optimise the commercialisation of patents and
other intellectual property within the Partner Companies.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAAFFEASXFAF
(END) Dow Jones Newswires
November 02, 2017 03:00 ET (07:00 GMT)
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Sep 2023 to Sep 2024